首页> 外国专利> QUANTITATIVE ASSESSMENT OF HUMAN T-CELL REPERTOIRE RECOVERY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

QUANTITATIVE ASSESSMENT OF HUMAN T-CELL REPERTOIRE RECOVERY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

机译:同种异体造血干细胞移植后人体T细胞库恢复的定量评估

摘要

A method and an apparatus are provided for determining T-cell repertoire recovery after allo-HSCT or identifying patients at high risk of infection. Combination of 5-RACE PCR with deep sequencing was used to quantify TCR diversity in 33 individuals using a single oligonucleotide pair. Analysis of duplicate blood samples revealed highly reproducible detection of expanded TCR clonotypes. After 6 months, recipients of cord blood grafts without anti-thymocyte globulin therapy approximated the TCR diversity of healthy subjects, whereas recipients of T-cell-depleted peripheral blood stem cell grafts had a 28-fold and 14-fold lower CD4+ and CD8+ T-cell diversity, respectively. After 12 months, these differences had leveled out for the CD4+, but not the CD8+ T-cell compartment.
机译:提供了一种方法和设备,用于确定同种HSCT后T细胞库的恢复或鉴定高感染风险的患者。 5-RACE PCR与深度测序的组合用于使用单个寡核苷酸对量化33位个体的TCR多样性。对重复血液样本的分析显示,扩展的TCR克隆型的检测具有高度可重复性。 6个月后,未接受抗胸腺细胞球蛋白疗法的脐带血接受者的TCR多样性接近健康受试者,而T细胞耗竭的外周血干细胞移植者的CD4 +和CD8 + T降低了28倍和14倍-细胞多样性。 12个月后,CD4 +的这些差异已趋于平稳,但CD8 + T细胞区室的差异尚未消除。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号